HAYWARD, Calif., March 12, 2013 /PRNewswire/ -- Solta Medical,
Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics
market, today announced that it will present at the 25th
Annual ROTH Growth Stock Conference, at the Ritz Carlton Hotel in
Dana Point, CA, on Monday, March 18, 2013 at 9:00 am PT. Stephen
J. Fanning, Chairman, President and Chief Executive Officer
of Solta Medical, will review the company's business strategy and
recent corporate events.
Solta will offer a live audio webcast of the presentation which
may be accessed at the Investor Relations section of the Company's
website at www.solta.com.
About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics
market providing innovative solutions with proven efficacy and
safety backed by over 10 years of clinical study and research. The
company offers aesthetic energy devices for skin resurfacing and
rejuvenation, acne reduction, body contouring and skin tightening,
as well as tools and accessories to optimize the latest liposuction
techniques. The Solta Medical portfolio includes the well-known
brands Thermage®, Fraxel®,
Clear + Brilliant®, Liposonix®,
Isolaz®, CLARO®,
VASERlipo™, VASERshape™,
VASERsmooth™, VentX®,
PowerX®, TouchView®, and
Origins™, which collectively make up a
comprehensive platform to address a range of aesthetic skin and
body issues. More than two and a half million procedures have been
performed with Solta Medical's products around the world. Solta
Medical is headquartered in Hayward,
CA with field teams and regional offices worldwide.
SOURCE Solta Medical, Inc.